Johne's Disease Diagnostics Market Size
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.10 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Johne's Disease Diagnostics Market Analysis
The Johne's disease diagnostics market is expected to register a CAGR of 5.10% over the forecast period.
The COVID-19 pandemic resulted in a decline in the market for Johne's disease diagnostics. This negative impact is due to the closure of and restricted access to veterinary diagnostics due to lockdown and social distancing norms. For instance, in April 2022, an article published by the Indian Journals of Animal Science showed a significant decline in the number of hospital cases attended by veterinarians, with a major decline in pets (54.9%), followed by goats (35.3%), and sheep (29%) being observed during the lockdown. However, the demand steadily recovered as governments started to relax their stay-at-home policies. Inefficiencies in field testing and remote collaboration were other challenges brought on by the COVID-19 pandemic. Over the forecast period, the market for Johne's disease diagnostics is estimated to grow notably, owing to the rising demand for rapid and easy diagnostic products and comparatively lax regulatory supervision. The US FDA does not mandate that manufacturers who exclusively market or manufacture veterinary devices list their devices or register their establishments. Thus, the pandemic has had a profound impact on the market.
The increase in animal health and diagnostics companies, the increase in veterinary healthcare expenditure, and increased awareness about paratuberculosis and Johne's disease eradication programs are some of the growth factors driving market growth.
Furthermore, the market growth for Johne's disease diagnostics is being supported by constant innovation in the veterinary diagnostics sector. For instance, Zoetis announced the addition of digital cytology testing to their VETSCAN IMAGYST platform, which was introduced in September 2020 and March 2022. VETSCAN IMAGYST provides access to a network of remote professional clinical diagnosticians as well as AI technologies for fecal testing. Additionally,
In April 2022, PDB Biotech launched Johne's disease testing services. PDB Biotech's new quick testing service will allow farmers to determine in days whether bulk milk or blood samples contain Mycobacterium avium subspecies paratuberculosis (MAP), the organism that causes Johne's disease. To identify the presence of live mycobacteria in a sample of blood or bulk milk, the service uses the diagnostic test Actiphage.
Moreover, increasing awareness regarding tuberculosis and vaccination programs is also propelling the growth of the market. For instance, the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service's Veterinary Services department (USDA-APHIS-VS) has developed a Johne's disease curb program for preventing the spread of the disease to non-infected herds. It has developed a cooperative federal-state-industry program for providing producer assistance by performing risk assessments. It is also working on providing funding for research for the development and validation of control measures.
Furthermore, veterinary medicine has historically outperformed human treatment in terms of diagnostic results and client calls returned. In-clinic digital cytology scanners from IDEXX and Antech are now advancing the industry's development and productivity by providing quick results, improving client adherence and happiness, and connecting veterinarians to pathologists. Therefore, owing to the aforementioned factors, it is anticipated that the studied market will witness growth over the analysis period.
Johne's Disease Diagnostics Market Trends
This section covers the major market trends shaping the Johne's Disease Diagnostics Market according to our research experts:
The Cattle Segment is Expected to Witness Growth Over the Forecast Period.
The cattle segment is expected to witness significant growth in the Johne's disease diagnostics market over the forecast period. The cattle segment includes cows, bulls, oxen, calves, and buffaloes. Increased zoonotic disease incidence in cattle is likely to drive vertebral expansion.
Furthermore, continuous new product developments in Johne's disease diagnostics launched by major players in the market are positively affecting the growth of the segment. A New Zealand biotech company, for example, will release a multiplexed diagnostic test for John's disease in June 2022.It makes it possible to track complicated diseases through several stages of infection by using biomarkers that are present at different points in the infection cycle, including asymptomatic stages. This is different from traditional Elisa, which only detects a disease at a single point in time.
The segmental growth is also attributable to rising supportive initiatives and eradication programs. For instance, the Irish Johne's Control Programme (IJCP) is a long-term voluntary control program for Johne's disease (JD) in Ireland, with strong support from the Irish cattle industry. It takes advantage of the formation of Animal Health Ireland to combat animal diseases not covered by EU regulations. Furthermore, it has four goals: prevent the transmission of JD to uninfected farms, reduce the degree of infection when it exists, ensure JD control markets in Ireland, and promote calf health and farm biosecurity. Therefore, the cattle segment is expected to witness significant growth over the forecast period due to the above-mentioned factors.
North America is Expected to Dominate the Johne's Disease Diagnostics Market
Over the next few years, North America is expected to be the biggest market for Johne's disease diagnostics. This is because of things like the growing Johne's disease eradication effort, the growing animal population, spending, and the presence of key players.
The regional market for Johne's disease diagnostics is now being supported by constant innovation in the veterinary diagnostics sector. For instance, in July 2020, VMRD obtained USDA approval for the testing of goat serum on their John's antibody test kit. This is a new thing that comes on top of the USDA license for bovine serum and milk samples, for which this test is already used in U.S. labs.
Moreover, the large market share of the region in the Johne's disease diagnostics market can be attributed to the local presence of major players, such as Thermo Fisher Scientific, Inc., Zoetis, and IDEXX, which are involved in the development and introduction of tests required for the diagnosis of Johne's disease. Collaborations between local and international companies and acquisitions are also expected to fuel market growth in the region. For instance, in April 2020, Zoetis completed the acquisition of Performance Livestock Analytics to improve its animal health solutions across the continuum of care for beef producers. Because of these factors, it is likely that the studied market will grow in the North American region.
Johne's Disease Diagnostics Industry Overview
The Johne's disease diagnostics market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, including PBD Biotech Ltd., Zoetis, Idexx Laboratories Inc., IDvet, Thermo Fisher Scientific Inc., VMRD Inc., Biomerieux SA, HIMEDIA, Promega Corporation, and Pictor Diagnostics, among others.
Johne's Disease Diagnostics Market Leaders
-
Zoetis
-
Idvet
-
Thermo Fisher Scientific
-
Idexx Laboratories
-
Pbd Biotech
*Disclaimer: Major Players sorted in no particular order
Johne's Disease Diagnostics Market News
- September 2020: Zoetic launched Vetscan Imagys, a new diagnostic platform to detect intestinal parasites in pets at the time of visit. It is used to detect intestinal parasites in animals through a fecal examination. The diagnostic environment in veterinary medicine is changing because of technological advancements. From distinct, clean sample preparation to analysis, Vetscan Imagyst provides a cutting-edge solution for fecal testing.
- June 2022: Pictor Limited developed an accurate, affordable, multiplexed diagnostic test for Mycobacterium avium paratuberculosis. It is a multiplexed enzyme-linked immunosorbent assay that technologically allows multiple biomarkers to be tested in a single well, and it has a positive addition to national control programs to help in the eradication of John's disease in the dairy industry.
Johne's Disease Diagnostics Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing of Numerous Animal Health and Diagnostics Companies
- 4.2.2 Rise in Veterinary Healthcare Expenditure
- 4.2.3 Johne's Disease Eradication Programs and Increased Awareness on Paratuberculosis
-
4.3 Market Restraints
- 4.3.1 Negligence and Lack of Awareness
- 4.3.2 Time-Consuming R&D Processes
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Animal Type
- 5.1.1 Cattle
- 5.1.2 Goat
- 5.1.3 Sheep
-
5.2 By Test Type:
- 5.2.1 Enzyme-linked immunoassay
- 5.2.2 Polymerase Chain Reaction
- 5.2.3 Agar gel immunodiffusion test
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle-East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Pbd Biotech Ltd
- 6.1.2 Zoetis
- 6.1.3 Idexx Laboratories, Inc.
- 6.1.4 Idvet
- 6.1.5 Thermo Fisher Scientific, Inc.
- 6.1.6 Vmrd, Inc.
- 6.1.7 Biomerieux Sa
- 6.1.8 HIMEDIA
- 6.1.9 Promega Corporation
- 6.1.10 Pictor diagnostics
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityJohne's Disease Diagnostics Industry Segmentation
As per the scope of the report, Johne's disease diagnostics are used in dealing with chronic, progressive intestinal disease caused by infection with Mycobacterium avium subspecies paratuberculosis (MAP), which affects primarily ruminant animals. The market is segmented by animal type (cattle, goats, and sheep), test type (enzyme-linked immunoassay, polymerase chain reaction, and agar gel immunodiffusion test), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The report offers the value (in USD million) for the above segments.
| By Animal Type | Cattle | |
| Goat | ||
| Sheep | ||
| By Test Type: | Enzyme-linked immunoassay | |
| Polymerase Chain Reaction | ||
| Agar gel immunodiffusion test | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Johne's Disease Diagnostics Market Research FAQs
What is the current Johne's Disease Diagnostics Market size?
The Johne's Disease Diagnostics Market is projected to register a CAGR of 5.10% during the forecast period (2024-2029)
Who are the key players in Johne's Disease Diagnostics Market?
Zoetis, Idvet, Thermo Fisher Scientific, Idexx Laboratories and Pbd Biotech are the major companies operating in the Johne's Disease Diagnostics Market.
Which is the fastest growing region in Johne's Disease Diagnostics Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Johne's Disease Diagnostics Market?
In 2024, the North America accounts for the largest market share in Johne's Disease Diagnostics Market.
What years does this Johne's Disease Diagnostics Market cover?
The report covers the Johne's Disease Diagnostics Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Johne's Disease Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Johne's Disease Diagnostics Industry Report
Statistics for the 2024 Johne's Disease Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Johne's Disease Diagnostics analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
